Department of Physiology, Harold Hamm Diabetes Center, The University of Oklahoma Health Science Center, Oklahoma City, United States ...

The company aims to supercharge antibody treatments using specially designed protein “cages” that multiply their effects, opening up new opportunities in drug development. The company was spun ...

Ueda is holding an expandable toy that he uses to demonstrate how the company’s computationally designed Antibody Cages work. (GeekWire Photo / Alan Boyle) Three weeks after University of ...

Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi 465-8603, Japan Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural ...

Novel antibody platform tackles viral mutations Findings may shape future drug development and pandemic response Date: October 23, 2024 Source: The Mount Sinai Hospital / Mount Sinai School of ...

About clesrovimab (MK-1654) Clesrovimab (MK-1654) is an investigational, extended half-life monoclonal antibody (mAb) developed as a passive immunization for the prevention of RSV. Clesrovimab is ...

Knockdown efficiency was confirmed by Western blot and flow cytometry, using the following antibodies ... JS-81 (BD Biosciences), and mouse anti-GAPDH (Abcam). GAPDH was used as a loading control.